The new report by Expert Market Research titled, ‘Global Biologics Market Trends, Size, Share, Growth, Scope, Report and Forecast 2022-2027’, gives an in-depth analysis of the global biologics market, assessing the biologics market based on its segments like sources, product types, manufacturing, disease categories, and major regions.
The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analyzing the market based on the SWOT and Porter’s Five Forces models.
Request a free sample copy in PDF or view the report summary@ https://www.expertmarketresearch.com/reports/biologics-market/requestsample
The key highlights of the report include:
Market Overview (2017-2027)
Forecast CAGR (2022-2027): 4.1%
Geographically, North America occupies a significant share in the market growth of biologics. This is supported by the presence of several leading companies and the subsequent rising investments in the R&D sector. Meanwhile, the Asia Pacific region is expected to make significant contributions to the market in the coming years owing to the developing healthcare sector in the region.
Further, the market is anticipated to be driven by the dominance of microbial sources as a major portion of the product range has its source in the microbial expressions system, which are used during the treatment of several chronic diseases depending upon the type of monoclonal antibodies. The market is being further driven by the products used in cancer treatment applications.
Industry Definition and Segmentation
Biologics are defined as disease-modifying antirheumatic drugs (DMARDs). Also known as biological drugs, these are made from living organisms or consist of their components, such as blood, cells, genes, tissues, allergens, and recombinant proteins.
These drugs control the production of vital proteins, and aid in the modification of human hormones and cells while producing substances to activate and suppress the immune system.
Explore the full report with the table of contents@ https://www.expertmarketresearch.com/reports/biologics-market
On the basis of source, the market can be divided into:
- Microbial Source
- Mammalian Source
Based on product type, the market can be classified into:
- Monoclonal Antibodies
- Murine MABs
- Chimeric MABs
- Humanised MABs
- Human MABs
- Recombinant Proteins
- Antisense, RNAi and Molecular Therapy
The market, based on manufacturing, can be distinguished into:
On the basis of disease category, the market is segmented into:
- Infectious Disease
- Immunological Disorders
- Cardiovascular disorders
- Haematologic Disorders
The regional markets for biologics include:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
The growth in the global market for biologics is being driven by the exceeding cases of chronic disorders. As a result, the increase in demand for efficient diagnostics and treatment drugs is pushing the market growth of biologics.
Further, the year-by-year increase in cancer patients is propelling the need to modify therapies and introduce drugs that can enhance the immune system and destroy cancer-causing cells at the earliest.
This demand is likely to boost the market growth of biologics in the coming years. The growing research and development (R&D) activities by prominent market leaders are backed up by government initiatives and investments.
Key Market Players
The major players in the market are Samsung Biologics, Amgen Inc., Novo Nordisk A/S, Pfizer Inc., Merck & Co., Inc., Precision Biologics, Inc., and F. Hoffmann-La Roche AG, among others.
The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Read More Reports :
Cell Separation Technologies Market: https://www.expertmarketresearch.com/reports/cell-separation-technologies-market
Cell Lysis & Disruption Market: https://www.expertmarketresearch.com/reports/cell-lysis-and-disruption-market
medical devices manufacturers: https://www.expertmarketresearch.com/articles/top-medical-devices-companies
3D Cell Culture Market: https://www.expertmarketresearch.com/reports/3d-cell-culture-market
Allergy Diagnostics and Therapeutics Market: https://www.expertmarketresearch.com/reports/allergy-diagnostics-and-therapeutics-market
About Us :
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Media Contact :
Company Name: Claight Corporation
Contact Person: Louis Wane, Corporate Sales Specialist – U.S.A.
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gloud Street, Sheridan, WY 82801, USA